# Pilot Study on Immunotherapy for the Treatment of Persistant Peanut Allergy

> **NCT04974970** · PHASE1,PHASE2 · TERMINATED · sponsor: **University Hospital, Geneva** · enrollment: 12 (actual)

## Conditions studied

- Food Allergy
- Peanut Allergy

## Interventions

- **DRUG:** Peanut Immunotherapy

## Key facts

- **NCT ID:** NCT04974970
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-04-01
- **Primary completion:** 2022-04-19
- **Final completion:** 2022-04-19
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** early termination due to insufficient recruitment
- **Last updated:** 2023-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04974970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04974970, "Pilot Study on Immunotherapy for the Treatment of Persistant Peanut Allergy". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04974970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*